MyFinsight
Home
Compare
About
Recent SEC Filings
10/2
NIKE, Inc.
(NKE)
10/2
DARDEN RESTAURANTS INC
(DRI)
9/30
CONAGRA BRANDS INC.
(CAG)
9/29
Carnival Corp Ltd.
(CCL)
9/29
URANIUM ENERGY CORP
(UEC)
9/29
COPART INC
(CPRT)
9/24
BLACKBERRY Ltd
(BB)
9/24
PAYCHEX INC
(PAYX)
9/23
GENERAL MILLS INC
(GIS)
9/22
ADOBE INC.
(ADBE)
9/18
KROGER CO
(KR)
10/2
NIKE, Inc.
(NKE)
10/2
DARDEN RESTAURANTS INC
(DRI)
9/30
CONAGRA BRANDS INC.
(CAG)
9/29
Carnival Corp Ltd.
(CCL)
9/29
URANIUM ENERGY CORP
(UEC)
9/29
COPART INC
(CPRT)
9/24
BLACKBERRY Ltd
(BB)
9/24
PAYCHEX INC
(PAYX)
9/23
GENERAL MILLS INC
(GIS)
9/22
ADOBE INC.
(ADBE)
9/18
KROGER CO
(KR)
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
|
Compare
Income Overview
Net Income
-$128,319,000
EPS
-$1.1
Unit: Dollar
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Income Statement
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Revenues
0
0
0
0
Research and development
115,754,000
150,150,000
153,458,000
89,953,000
General and administrative
16,843,000
13,975,000
11,280,000
8,608,000
Total operating expenses
132,597,000
164,125,000
164,738,000
98,561,000
Loss from operations
-132,597,000
-164,125,000
-164,738,000
-98,561,000
Realized gain on investments, net
-
0
-
10,000
Amortization of financing costs
0
0
0
8,000
Interest income, net
4,545,000
5,800,000
7,035,000
7,772,000
Realized gain on investments
30,000
-
41,000
-
Total other income, net
4,575,000
5,800,000
7,076,000
7,774,000
Net loss
-128,022,000
-158,325,000
-157,662,000
-90,787,000
Unrealized (gain) loss on investments
-299,000
-1,250,000
-10,000
540,000
Foreign currency translation gain
2,000
16,000
14,000
0
Comprehensive loss
-128,319,000
-159,559,000
-157,658,000
-90,247,000
Basic EPS
-1.1
-1.37
-1.381
-0.81
Diluted EPS
-1.1
-1.37
-1.381
-0.81
Basic Average Shares
116,263,000
115,568,000
114,145,000
112,320,000
Diluted Average Shares
116,263,000
115,568,000
114,145,000
112,320,000
Page 1
Unit: Dollar. Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Income Statement
VKTX Income Statement Sankey Diagram
Sankey diagram visualizing VKTX income statement for the period
Comprehensive loss
-$128,319,000
(-95.87%↓ Y/Y)
Foreign currency
translation gain
$2,000
(-91.67%↓ Y/Y)
Interest income, net
$4,545,000
(-49.68%↓ Y/Y)
Realized gain on
investments
$30,000
Net loss
-$128,022,000
(-95.27%↓ Y/Y)
Unrealized (gain) loss on
investments
-$299,000
(-1250.00%↓ Y/Y)
Total other income,
net
$4,575,000
(-49.24%↓ Y/Y)
Loss from operations
-$132,597,000
(-77.81%↓ Y/Y)
Total operating
expenses
$132,597,000
(77.81%↑ Y/Y)
Research and development
$115,754,000
(92.43%↑ Y/Y)
General and
administrative
$16,843,000
(16.79%↑ Y/Y)
Buy us a coffee
viking_9_15_logo-svg
Viking Therapeutics, Inc. (VKTX)
viking_9_15_logo-svg
Viking Therapeutics, Inc. (VKTX)